Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Pain Therapeutics (PTIE)

4.36 +0.05 (+1.16%)

5/25/2017  4:00pm

Open:

4.34

Pre. Close:

4.31

High:

4.55

Low:

4.26

Volume:

83,242

Market Cap:

28.74M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.61 - 4.67

4.67 - 4.72

Low:

4.11 - 4.16

4.16 - 4.2

Close:

4.27 - 4.38

4.38 - 4.46

Technical analysis  (as of: 2017-05-25 4:48:53 PM)

Overall:

      

Stoxline posted a STRONG BUY today, same as yesterday. This stock still seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 5.99     One year: 6.95

Support:

Support1: 3.79    Support2: 3.15

Resistance:

Resistance1: 5.12    Resistance2: 5.95

Pivot:

4.46

Moving Averages:

MA(5): 4.17     MA(20): 4.77

MA(100): 4.79     MA(250): 8.71

MACD:

MACD(12,26): -0.35     Signal(12,26,9): -0.32

%K %D:

%K(14,3): 22.34     %D(3): 15.10

RSI:

RSI(14): 42.06

52-Week:

High: 21.00  Low: 3.57  Change(%): -73.2

Average Vol(K):

3-Month: 187  10-Days 80

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
PTIE has closed above bottom band by 43.6%. Bollinger Bands are 14.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 21 Mar 2017 09:41:16 GMT
Pain Therapeutics' Remoxy ER Secures FDA Regulatory Guidance (PTIE, EGLT)

Thu, 25 May 2017 10:07:30 GMT
Hot On The Charts: Paratek Pharmaceuticals, Inc. (PRTK), Pain Therapeutics ...

Fri, 14 Apr 2017 22:30:27 GMT
BRIEF-Pain Therapeutics files for mixed shelf of up to $75 mln

Mon, 08 May 2017 13:07:30 GMT
Pain Therapeutics Announces Reverse Stock Split

Tue, 09 May 2017 19:18:45 GMT
Drilling Down Into Pain Therapeutics, Inc. (PTIE)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

Shares Float (M)

4.99

% Held by Insiders

23.38

% Held by Institutions

45.30

Shares Short (K)

838

Shares Short Prior Month (K)

817

Stock Financials

EPS

-1.840

EPS Est. Current Year

1.290

EPS Est. Next Year

-3.090

EPS Est. Next Quarter

-0.550

Forward EPS

Book Value (p.s.)

2.540

PEG Ratio

0.04

Profit Margin

Operating Margin

Return on Assets (ttm)

-36.5

Return on Equity (ttm)

-61.9

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.323

Qtrly Earnings Growth

Operating Cash Flow (M)

-12.23

Levered Free Cash Flow (M)

-6.88

FoxReading.com

Valuation

P/E

-2.37

P/E Growth Ratio

0.01

P/BV

1.72

P/S

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2012-12-24

Ex-Dividend Date

2012-12-13

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.